National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 16217 [2017-06403]
Download as PDF
<![CDATA[
mstockstill on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 82, No. 62 / Monday, April 3, 2017 / Notices
preparedness and response. Pursuant to
the Federal Advisory Committee Act
(FACA) of 1972 (5 U.S.C., Appendix, as
amended), and section 2811A of the
Public Health Service (PHS) Act (42
U.S.C. 300hh–10a), as added by section
103 of the Pandemic and All Hazards
Preparedness Reauthorization Act of
2013 (Pub. L. 113–5), the HHS
Secretary, in consultation with the
Secretary of the U.S. Department of
Homeland Security, established the
NACCD. The purpose of the NACCD is
to provide advice and consultation to
the HHS Secretary with respect to the
medical and public health needs of
children in relation to disasters.
Background: The NPRSB public
meeting on April 12, 2017, will be
dedicated to the swearing-in of one new
voting member and the re-appointment
of five existing members. The NPRSB
and NACCD will hold a joint public
meeting and ASPR Day on April 13,
2017, with presentations on ASPR
priorities, the National Health Security
Strategy, and stakeholder updates.
Subsequent agenda topics will be added
as priorities dictate. Any additional
agenda topics will be available on the
April 12 and 13, 2017 meeting Web
pages of the NPRSB and NACCD, which
are available at https://www.phe.gov/
nprsb and https://www.phe.gov/naccd.
Availability of Materials: The joint
meeting agenda and materials are posted
prior to the meeting on April 12 and 13,
2017 meeting Web pages at https://
www.phe.gov/nprsb and https://
www.phe.gov/naccd.
Procedures for Providing Public Input:
Members of the public attend in-person
or by teleconference via a toll-free callin phone number, which is available on
the NPRSB or NACCD Web sites at
https://www.phe.gov/nprsb and https://
www.phe.gov/naccd. All members of the
public are encouraged to provide
written comment to the NPRSB and
NACCD. Submit all written comments
prior to April 12, 2017, to their Web
sites, under the ‘‘Contact Us’’ link, at
https://www.phe.gov/nprsb and https://
www.phe.gov/naccd with ‘‘NACCD
Public Comment’’ or ‘‘NPRSB Public
Comment’’ as the subject line. Public
comments received by close of business
one week prior to the teleconference are
distributed to the NACCD or NPRSB.
Dated: March 13, 2017.
George W. Korch, Jr.,
Acting Assistant Secretary for Preparedness
and Response.
[FR Doc. 2017–06409 Filed 3–31–17; 8:45 am]
BILLING CODE 4150–28–P
VerDate Sep<11>2014
18:32 Mar 31, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; AIDSRRC Independent SEP.
Date: April 25, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Peter R. Jackson, Ph.D.,
Chief, AIDS Research Review Branch,
Scientific Review Program, Division of
Extramural Activities, Room #3G20, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5049, pjackson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: March 28, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06403 Filed 3–31–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health (NIH)
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of an Interagency Autism
Coordinating Committee (IACC or
Committee) meeting.
The purpose of the IACC meeting is
to discuss business, agency updates, and
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
16217
issues related to autism spectrum
disorder (ASD) research and services
activities. The Committee will discuss
the 2017 update of the IACC Strategic
Plan. The meeting will be open to the
public and will be accessible by webcast
and conference call.
Name of Committee: Interagency
Autism Coordinating Committee (IACC).
Type of meeting: Open Meeting.
Date: April 26, 2017.
Time: 9:00 a.m. to 5:00 p.m.* Eastern
Time * Approximate end time.
Agenda: To discuss business, updates,
and issues related to ASD research and
services activities. The Committee will
discuss updates of the IACC Strategic
Plan.
Place: National Institutes of Health,
31 Center St, Building 31, C Wing, 6th
Floor, Conference Room 6, Bethesda,
MD 20892.
Webcast Live: https://
videocast.nih.gov.
Conference Call Access: Dial: 800–
857–9708; Access code: 4617338.
Cost: The meeting is free and open to
the public.
Registration: A registration web link
will be posted on the IACC Web site
(www.iacc.hhs.gov) prior to the meeting.
Pre-registration is recommended to
expedite check-in. Seating in the
meeting room is limited to room
capacity and on a first come, first served
basis. Onsite registration will also be
available.
Deadlines:
Notification of intent to present oral
comments: Friday, April 14, 2017 by
5:00 p.m. ET.
Submission of written/electronic
statement for oral comments: Tuesday,
April 18, 2017 by 5:00 p.m. ET.
Submission of written comments:
Tuesday, April 18, 2017 by 5:00 p.m.
ET.
For IACC Public Comment guidelines
please see: https://iacc.hhs.gov/
meetings/public-comments/guidelines/.
Access: Medical Center Metro Station
(Red Line).
Contact Person: Ms. Angelice
Mitrakas, Office of Autism Research
Coordination, National Institute of
Mental Health, NIH, 6001 Executive
Boulevard, Room 6182A, Bethesda, MD
20892–9669, Phone: 301–435–9269,
Email: IACCPublicInquiries@
mail.nih.gov.
Public Comments
Any member of the public interested
in presenting oral comments to the
Committee must notify the Contact
Person listed on this notice by 5:00 p.m.
ET on Friday, April 14, 2017, with their
request to present oral comments at the
meeting, and a written/electronic copy
E:\FR\FM\03APN1.SGM
03APN1
]]>Agencies
[Federal Register Volume 82, Number 62 (Monday, April 3, 2017)]
[Notices]
[Page 16217]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06403]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; AIDSRRC Independent SEP.
Date: April 25, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Peter R. Jackson, Ph.D., Chief, AIDS Research
Review Branch, Scientific Review Program, Division of Extramural
Activities, Room #3G20, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5049,
pjackson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS).
Dated: March 28, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-06403 Filed 3-31-17; 8:45 am]
BILLING CODE 4140-01-P
